Skip to content

Derrell Porter, Director at Acumen Pharmaceuticals, sold ABOS on Jun 17, 2026

Data as of Oct 27

▼ SELL$30.3K13,040 shares at $2.33Derrell Porter DirectorABOS Acumen Pharmaceuticals, Inc.
Watch ABOS
Traded
Jun 17, 2026
Disclosed
Jun 17, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Derrell Porter, Director at Acumen Pharmaceuticals, sold ABOS on Jun 17, 2026TRADEDDISCLOSED
ABOSSimilar stocks (XLV — its sector index fund), rebased to ABOS's price on the disclosure day
ABOS since disclosure
+0.4%
after the sale
Similar stocks (XLV) since disclosure
+18.9%
XLV — its sector index fund

Change in closing price from Jun 17, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLDerrell Porter DirectorABOS Acumen Pharmaceuticals, Inc.$29.8Kdisclosed Jun 17 · filed 1 day after the trade
  2. ▼ SELLDerrell Porter DirectorABOS Acumen Pharmaceuticals, Inc.$15.1Kdisclosed Jun 17 · filed 2 days after the trade

See every trade on ABOS →